Safety Rates Drug Report: CLARAVIS Exposure via body fluid adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: CLARAVIS Injury: Exposure via body fluid Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 2 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
127597571	CLARAVIS	Exposure via body fluid	TEVA	0.00	M	0	20160919	US
127618161	CLARAVIS	Exposure via body fluid	TEVA	0.00	M	0	20160920	US

|< 1/2 << Previous Page Page 1

Total Records: 2 Number of Pages: 1

Execution Time: 0.0450119972229 seconds (ucode:4914162). Developed by: James D. Barger